Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Divalproex Sodium NDC 70518-1558 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Divalproex Sodium 500mg 70518 1558 01
Divalproex Sodium is a medication in a tablet form of 500mg. It is used only with the prescription of the doctor. The tablets are packed in a quantity of 100 HD2. The medication should be kept out of the reach of children, stored at a temperature of 20-26°C (63-77°F); excursions permitted to 15-30°C (59-86°F) [See USP]. The package insert should be followed for the instructions of use. The tablets were repackaged by RemedyRepack Inc., Indiana, PA 15701. The LOT # and Expiry date are not available.*
Divalproex Sodium 500mg 70518 1558 02
Divalproex Sodium is a delayed-release medication. The product has an NDC number of 70518-1558-02 and is sourced from Sun Pharma in Cranbury, N.J. The LOT number and expiration date of the product are not provided. The medication should be kept out of the reach of children and stored between 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F) as indicated by U.S. Pharmacopeia (USP). The directions for use are provided in the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA.*
Remedy_Label - Remedy Label
Divalproex Sodium is a medication administered in the form of a 500mg delayed-release tablet. It is RX Only and should be kept out of children's reach. The medication is manufactured by Sun Pharma of Cranbury, N.J. 08512. The medicine should be stored in a dry and cool place, and the instructions to use the drug are to be found in the package insert. The medication has been repackaged by RemedyRepack. The LOT # and expiration date are missing.*
spl-divalproex-figure-1 - spl divalproex figure 1
spl-divalproex-figure-2 - spl divalproex figure 2
This appears to be a graph with two lines labeled "DVPX" and "Placebo" showing the percentage of patients with an improvement, no change, or worsening, along with a scale ranging from -100% to 100% and a "Reduction in CPS Rate" label. Not enough context is provided to determine what "CPS" refers to or what the two lines represent without additional information.*
spl-divalproex-figure-3 - spl divalproex figure 3
spl-divalproex-figure-4 - spl divalproex figure 4
The text describes Figure 4 which contains information about the mean 4-week migraine rates for a placebo and a drug called DVPX from Study 1 and Study 2.*
spl-divalproex-structure - spl divalproex structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.